Spore Wellness Immune (SWI)?is a blend of Golden Teacher (psilocybe cubensis), Reishi (ganoderma lucidum), Chaga (inonotus obliquus), and Organic Ginger.Microdosing Mushroom Capsules
Our unique non-intoxicating formula is ideal for those looking to give their insides a healthy boost.
Each bottle of SWI contains 25 capsules (500mg per capsule). Vegan and gluten free.
Reishi (ganoderma lucidum) is often called the queen of mushrooms. It is known to activate immune cells by its high triterpenoid content, an active compound known to protect the liver and kidney. Reishi is also an anti-oxidant, anti-histamine and is anti-inflammatory. Traditionally it has been used to sooth the digestive tracks, and also has been used to aid the lung for conditions such as asthma and bronchitis. Microdosing Mushroom Capsules
Chaga (inonotus obliquus) is often called the king of mushrooms. Found on birch trees in cold climates, it contains an abundance of polysaccharides within its chitin walls that are known to boost energy. Chaga is known to support gastrointestinal and liver health and assist in your overall cardiovascular health. It is also known to have anti-viral, anti-cancer and anti-inflammatory traits.
Recommend Use: Promotes & supports immune system health.
Benefits of Microdosing: Non-psychoactive,? Improved mood, Increased creativity, Improved focus, Improved energy, Improved memory, and Self-efficacy. Microdosing psychedelics is the practice of consuming very low, sub-hallucinogenic doses of a psychedelic substance, such as lysergic acid diethylamide (LSD) or psilocybin-containing mushrooms. According to media reports, microdosing has grown in popularity, yet the scientific literature contains minimal research on this practice. There has been limited reporting on adverse events associated with microdosing, and the experiences of microdosers in community samples have not been categorized Microdosing Mushroom Capsules
In the present study, we develop a codebook of microdosing benefits and challenges (MDBC) based on the qualitative reports of a real-world sample of 278 microdosersMicrodosing research complements the full-dose literature categorized